Ronald Lau
Family Medicine · East Brunswick, NJNPI 1558466623
Payments from drug & device makers
Across 196 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$784
- AbbVie$495
- Pfizer$350
- Esperion Therapeutics, Inc.$314
- Novo Nordisk$305
- Johnson & Johnson$265
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,49699%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 31 | $784 |
| AbbVie(2 entities) | 31 | $495 |
| Pfizer | 14 | $350 |
| Esperion Therapeutics, Inc. | 27 | $314 |
| Novo Nordisk | 14 | $305 |
| Johnson & Johnson | 8 | $265 |
| Amarin Pharma, Inc. | 22 | $250 |
| Boehringer Ingelheim | 11 | $150 |
| Lilly USA, LLC | 10 | $148 |
| Biohaven Pharmaceuticals, Inc. | 3 | $97 |
| Merck | 5 | $71 |
| Eisai Inc. | 5 | $68 |
| GSK | 3 | $42 |
| Amgen | 2 | $28 |
| Novartis | 1 | $25 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Exact Sciences | 1 | $21 |
| Bayer | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Cequr Corporation | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,526 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,625 |
| Atorvastatin Calcium | 53 | $692 |
| Metoprolol Succinate | 29 | $429 |
| Rosuvastatin Calcium | 18 | $413 |
| Levothyroxine Sodium | 28 | $374 |
| Losartan Potassium | 23 | $345 |
| Olmesartan Medoxomil | 11 | $309 |
| Metformin Hcl | 13 | $217 |
| Bupropion XlBupropion Hcl | 16 | $191 |
| Lisinopril | 16 | $142 |
| Amlodipine Besylate | 27 | $121 |
| Pravastatin Sodium | 11 | $119 |
| Hydroxyurea | 11 | $119 |
| Famotidine | 20 | $112 |
| Simvastatin | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $350 | $7,62512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in East Brunswick
- Venkataranga NallapareddygariEast Brunswick$132K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.